FDA Law Blog

JANUARY 3, 2024

Palmer & Riëtte van Laack — Most of us love our furry friends, and with the boom in pet ownership during the pandemic, it is no surprise that the market for pet products has become enormous. CVM does not regulate the practice of veterinary medicine (that’s a state licensing board) or vaccines for animal diseases (that’s USDA).

Drugs 59

Drugs Licensing Licensing Production 59

Pharmaceutical Technology

MAY 24, 2023

It is also licensed by Spain’s Centro de Investigación Biomédica en Red de Enfermedades Raras, the Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz and the Centro de Investigaciones Energéticas, Medioambientales y Tecnológicas. The therapy has also received orphan drug and fast-track designations.

Gene Therapy 130

Gene Therapy Gene Licensing Licensing 130

Camargo

DECEMBER 13, 2021

The development of biological products (or biologics) represents a major advancement in modern medicine, enabling the treatment of patients with many illnesses where no other therapeutics were previously available. The regulations regarding BLAs for therapeutic biological products are included in 21 CFR parts 600 , 601 , and 610.

Development 161

Development Production Immune Response Licensing 161

XTalks

JUNE 5, 2023

Ozempic and Wegovy, which contain the active ingredient semaglutide, were approved by the US Food and Drug Administration (FDA). GLP-1 stimulates insulin production, thus reducing blood glucose levels, and it interacts with the brain to suppress appetite and create a feeling of fullness. mg and 2.4 mg doses of Wegovy.

FDA Approval 98

FDA Approval Containment Drugs Pharmacy 98

FDA Law Blog

FEBRUARY 26, 2024

Relevant here, FDA interpreted in Guidance that a proposed injectable biosimilar must “demonstrate that its product has the same strength as the reference product by demonstrating that both products have the same total content of drug substance (in mass or units of activity) and the same concentration of drug substance.”

Production 59

Production Bioequivalency Drugs Containment 59

The Pharma Data

DECEMBER 15, 2020

Under the agreement, Aurena Laboratories will establish a production unit to meet the regulatory requirements for the manufacture of Lipidor’s pharmaceutical products. This will enable Lipidor to offer potential licensees the opportunity for large-scale commercial production.

Contract Manufacturing 52

Contract Manufacturing Manufacturing Production Drugs 52

Druggist

JULY 22, 2020

With its sedative properties, promethazine can be used as sleeping aid product; however, it can also be used as an antihistamine for the treatment of allergic conditions including allergic rhinitis, itchiness of the skin and to help with mild anaphylactic reactions. There are no products in the UK marketed as promethazine cough syrup.

Nurses 52

Nurses Pharmacy Containment Licensing 52

The Pharma Data

MAY 7, 2021

population in just a few months, the BLA submission is an important cornerstone of achieving long-term herd immunity and containing COVID-19 in the future,” said Ugur Sahin, M.D., The Pfizer-BioNTech COVID-19 Vaccine has not been approved or licensed by the U.S. The information contained in this release is as of May 7, 2021.

Licensing 52

Licensing Licensing Vaccination Vaccine 52

The Pharma Data

JANUARY 11, 2021

a San Diego-based biotechnology company with an array of technology platforms for antibody discovery and optimization, and novel NK and T cell engager generation, today announced licensing of a panel of its anti-SARS-CoV-2 antibody clones to IGM Biosciences for COVID-19 therapy development.

Antibody 52

Antibody Licensing Licensing Development 52

Advarra

APRIL 30, 2024

Investigator Site Files The ISF contains essential documents permitting evaluation of a clinical trial’s conduct. A cross-check ensures curriculum vitae (CVs), and medical licenses (if appropriate) are on file and current. Both the medical licenses and nurse licenses need to be up to date. Sites outside of the U.S.

Licensing 52

Licensing Licensing Pharmacy Clinical Trials 52

Camargo

NOVEMBER 11, 2020

Unpacking the (Black) Box: Antares Licenses Urology Product with Boxed Warning. When the FDA requires a product’s labeling to include a boxed warning (also called a “black box warning” because the text is surrounded by black border), the potential market value of the drug often drops severely. In October, the U.S.

Development 242

Development Bioequivalency Generic Drugs Production 242

FDA Law Blog

JULY 18, 2023

Forty percent of those sites are in what CDER terms the “No Application” sector, meaning that those sites make over the counter (OTC) products, unapproved drugs, and homeopathic products, all sold without premarket approvals. That leaves 60% that manufacture at least one application product.

Manufacturing 52

Manufacturing Contamination Production Drugs 52

Worldwide Clinical Trials

FEBRUARY 21, 2024

Regardless of the formulation, the entire dose must be administered to each subject, and the dosing containers must be checked for residual radioactivity. Dosing Our pharmacy services can prepare liquid, solid, and intravenous dosage formulations.

Clinical Trials 180

Clinical Trials Clinical Trials Pharmacy Trials 180

Druggist

AUGUST 3, 2020

Otrivine Extra Dual Relief is a pharmacy only medication and the only over the counter product containing ipratropium bromide for the management of congestion and runny nose caused by colds. Sale restrictions are related to indicated use of the product reflected by its license. How long have you had symptoms for?

Pharmacy 98

Pharmacy Containment Sales Production 98

The Pharma Data

MARCH 2, 2021

Bayer will introduce Vynyty Citrus ® , its latest biological and pheromone-based crop protection product to control pests on citrus farms during the International Symposium on Horticulture in Europe – SHE2021 , March 8-11. Promising results were achieved in tomato production in Spain. More than 500 are expected to attend.

Production 52

Production Development Research Licensing 52

The Pharma Data

DECEMBER 13, 2020

The FDA also recommended that Gamida Cell generate additional manufacturing-related data prior to requesting a pre-Biologics License Application (BLA) meeting. Omidubicel is the first bone marrow transplant cell therapy product to receive Breakthrough Therapy Designation from the FDA and has also received Orphan Drug Designation in the U.S.

Licensing 52

Licensing Licensing Clinical Trials Clinical Trials 52

Druggist

MAY 12, 2021

In this post, I will briefly review the use of Celevac,:what it is and talk about alternative options (prescription and over the counter products) which have similar use to Celevac. Celevac is a brand of tablets containing methylcellulose. Each Celevac tablet contained 500mg of methylcellulose. What is Celevac?

Containment 97

Containment Production Pharmacy Licensing 97

The Pharma Data

AUGUST 17, 2020

. (“Dragonfly”), today announced that they have entered into a definitive agreement under which Bristol Myers Squibb will be granted the global exclusive license to Dragonfly’s interleukin-12 (IL-12) investigational immunotherapy program, including its extended half-life cytokine DF6002.

Licensing 52

Licensing Licensing Development Production 52

Drug Discovery World

MAY 5, 2023

The acquisition will provide Eterna with a pipeline of allogeneic immuno-oncology products under development for the treatment of haematologic and solid tumours. Eterna plans to use Exacis’ platform to develop engineered cell therapies containing genomic edits designed to enhance their performance.

Gene Editing 52

Gene Editing Engineer DNA Life Science 52

Druggist

DECEMBER 28, 2020

The Government recently announced the reclassification of fexofenadine 120mg, which will be available as General sale Medication (GSL), sold as branded products – Allevia 120mg tablets. Fexofenadine over the counter – the first GSL product. Fexofenadine over the counter – the first GSL product.

Pharmacy 98

Pharmacy Doctors Doctor Allergies 98

World of DTC Marketing

MAY 24, 2022

DEA agents interviewed former Cerebral employees about clinician licensing issues and allegations that some patients had set up multiple accounts to obtain more drugs, Insider reported , citing sources. Many claims may or may not accurately reflect what these products offer, “It’s the wild west.”.

Licensing 252

Licensing Licensing Scientist Production 252

The Pharma Data

NOVEMBER 30, 2020

1, 2020 /PRNewswire/ — Sosei Group Corporation (“the Company”) (TSE: 4565) announces it has entered into a global collaboration and license agreement with Biohaven Pharmaceutical Holding Company Ltd. (“Biohaven”, NYSE: BHVN). . TOKYO and CAMBRIDGE, England , Dec. Vlad Coric , M.D.,

Licensing 40

Licensing Licensing Production Development 40

FDA Law Blog

SEPTEMBER 7, 2022

Number of Manufacturing Sites and Registered Products. 39% of these manufacturing sites are what is referred to as “no application” sites, meaning that the products manufactured there are without an approved FDA application, which includes over-the-counter (OTC) products, unapproved prescription drug products and homeopathic products.

Manufacturing 59

Manufacturing Production Containment Drugs 59

The Pharma Data

DECEMBER 13, 2020

. Relay Therapeutics will receive $75 million upfront and is eligible to receive an additional $25 million in near-term payments and $695 million in additional potential milestones, plus royalties on global net product sales. Relay Therapeutics to host conference call at 8:00 a.m. CAMBRIDGE, Mass., About RLY-1971.

Licensing 40

Licensing Licensing Clinical Trials Clinical Trials 40

The Pharma Data

DECEMBER 16, 2020

NASDAQ: AUPH / TSX:AUP) (“Aurinia” or the “Company”) today announced it has entered into a collaboration and license agreement with Otsuka Pharmaceutical Co., About Otsuka Otsuka Pharmaceutical is a global healthcare company with the corporate philosophy: “Otsuka-people creating new products for better health worldwide.”

Licensing 52

Licensing Licensing Development Sales 52

Druggist

DECEMBER 17, 2020

Without a doubt, codeine-containing products are one of the most commonly sold medicines in the UK. Most codeine products are combination products of codeine and another drug. Restrictions on the supply of codeine-containing products. Codeine over the counter: UK list of products. Codeine and aspirin.

Production 98

Production Containment Pharmacy Licensing 98

Druggist

NOVEMBER 1, 2020

Lidocaine patch (brand name: Versatis medicated plaster) is a prescription-only medication, which has limited licensed use in the UK. The UK licensed use of lidocaine Can you use lidocaine patch for back pain? As the name suggests, lidocaine patch is a medicated plaster which contains a local anaesthetic – lidocaine 5%.

Licensing 59

Licensing Licensing Containment Medicine 59

Druggist

JULY 15, 2020

Information reviewed in this post: Legal status and availability of Disprin Licensed use Age restrictions Contra-indications: who cannot use Disprin chewable aspirin Recommended dose Possible side-effects Alternative options Disprin Direct legal status The legal status of Dispirin Direct depends on the pack size of the product.

Pharmacy 59

Pharmacy Containment Production Medicine 59

Druggist

JANUARY 9, 2021

Smaller packs of paracetamol (contain 16 tablets or capsules) are available in all supermarkets and pharmacies for patient self-selection. There are plenty of paracetamol brands, most of which contain a standard adult dose of 500mg of paracetamol per tablet. Each Nurofen Meltlet contains 200mg of ibuprofen. Paracetamol.

Containment 98

Containment Pharmacy Production Drugs 98

The Pharma Data

DECEMBER 14, 2020

15, 2020 (GLOBE NEWSWIRE) — Burning Rock Biotech Limited (NASDAQ: BNR, the “Company” or “Burning Rock”) today announced that it entered into an exclusive licensing agreement with Oncocyte Corporation (NYSE American: OCX) to bring DetermaRx , a risk stratification test for early stage lung cancer patients, to China.

Licensing 52

Licensing Licensing Marketing Gene Expression 52

The Pharma Data

JANUARY 13, 2021

This is our sixth global approval for an internally-developed product, and our first approval for tislelizumab in a lung cancer indication, an area where we believe tislelizumab can have a large impact for patients.”. We also market or plan to market in China additional oncology products licensed from Amgen Inc.,

Production 52

Production Trials Antibody Clinical Trials 52

pharmaphorum

JANUARY 20, 2022

The Swiss subsidiary of Glenmark Pharmaceuticals and Lotus International have signed a licensing agreement whereby Glenmark will handle the manufacture and supply of Ryaltris and Lotus will take charge of commercialising the drug, subject to approval. with allergic rhinitis.

Allergies 70

Allergies Marketing Manufacturing Production 70

Drug Discovery World

FEBRUARY 6, 2023

Mesoblast has resubmitted its biologics license application (BLA) to the US Food and Drug Administration (FDA) for approval of remestemcel-L in the treatment of children with steroid-refractory acute graft versus host disease (SR-aGVHD). Our team has worked tirelessly over the past two years to provide a comprehensive response to the FDA.

Medicine 52

Medicine FDA Approval Licensing Licensing 52

The Pharma Data

DECEMBER 22, 2020

has been using an exclusively licensed antibody complex to develop new cancer therapies based on its Illuminox TM technology platform. is moving forward with product development by conducting clinical trials of monotherapy and combination therapy with other drugs. The approval and commercial success of the product may not be achieved.

Clinical Trials 52

Clinical Trials Clinical Trials Production Trials 52

Druggist

APRIL 6, 2021

LACRI-LUBE® Eye ointment (also marketed as Refresh Night Time® Eye ointment) is a pharmacy-only , preservative-free eye ointment licensed to lubricate and protect the eye associated with different eye conditions, for example, inflammation of the cornea of the eye, decreased corneal sensitivity, corneal erosions and eye surgery. . £5.90.

Pharmacy 93

Pharmacy Containment Sales Production 93

FDA Law Blog

MARCH 13, 2024

156 for certain FDA-regulated products, we know what you were thinking. Part 2 (“Part Deux”) investigated the PTO’s position and recent decisions on PTE applications for patents covering products approved—and then withdrawn years later—under the Federal Food, Drug, and Cosmetic Act’s Accelerated Approval provisions (and otherwise).

Marketing 59

Marketing Production FDA Approval Generic Drugs 59

The Pharma Data

MAY 27, 2022

ViiV Healthcare and MPP are actively negotiating voluntary licensing terms to help widen access to innovative HIV prevention measure . generic version of the product. These are challenges not only for ViiV Healthcare but also for any future generic licensees. About ViiV Healthcare.

Medicine 52

Medicine Licensing Licensing Manufacturing 52